BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 25689414)

  • 41. DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).
    Nowacka-Zawisza M; Wiśnik E
    Oncol Rep; 2017 Nov; 38(5):2587-2596. PubMed ID: 29048620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers.
    Yen CY; Huang HW; Shu CW; Hou MF; Yuan SS; Wang HR; Chang YT; Farooqi AA; Tang JY; Chang HW
    Cancer Lett; 2016 Apr; 373(2):185-92. PubMed ID: 26808576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenetic biomarkers: A new perspective in laboratory diagnostics.
    García-Giménez JL; Sanchis-Gomar F; Lippi G; Mena S; Ivars D; Gomez-Cabrera MC; Viña J; Pallardó FV
    Clin Chim Acta; 2012 Oct; 413(19-20):1576-82. PubMed ID: 22664147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genes, chromatin, and breast cancer: an epigenetic tale.
    Mielnicki LM; Asch HL; Asch BB
    J Mammary Gland Biol Neoplasia; 2001 Apr; 6(2):169-82. PubMed ID: 11501577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interaction between epigenetics, nutrition and the development of cancer.
    Bishop KS; Ferguson LR
    Nutrients; 2015 Jan; 7(2):922-47. PubMed ID: 25647662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic Alterations in Parathyroid Cancers.
    Verdelli C; Corbetta S
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28157158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
    Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
    Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation.
    Batra RN; Lifshitz A; Vidakovic AT; Chin SF; Sati-Batra A; Sammut SJ; Provenzano E; Ali HR; Dariush A; Bruna A; Murphy L; Purushotham A; Ellis I; Green A; Garrett-Bakelman FE; Mason C; Melnick A; Aparicio SAJR; Rueda OM; Tanay A; Caldas C
    Nat Commun; 2021 Sep; 12(1):5406. PubMed ID: 34518533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigenetic regulation and cancer (review).
    Chen QW; Zhu XY; Li YY; Meng ZQ
    Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast cancer epigenetics: from DNA methylation to microRNAs.
    Veeck J; Esteller M
    J Mammary Gland Biol Neoplasia; 2010 Mar; 15(1):5-17. PubMed ID: 20101446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigenomics and breast cancer.
    Lo PK; Sukumar S
    Pharmacogenomics; 2008 Dec; 9(12):1879-902. PubMed ID: 19072646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers.
    Zhang J; Huang K
    BMC Genomics; 2017 Jan; 18(Suppl 1):1045. PubMed ID: 28198667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer epigenetics: a perspective on the role of DNA methylation in acquired endocrine resistance.
    Trimarchi MP; Mouangsavanh M; Huang TH
    Chin J Cancer; 2011 Nov; 30(11):749-56. PubMed ID: 22035855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigenetic inactivation of the HOXA gene cluster in breast cancer.
    Novak P; Jensen T; Oshiro MM; Wozniak RJ; Nouzova M; Watts GS; Klimecki WT; Kim C; Futscher BW
    Cancer Res; 2006 Nov; 66(22):10664-70. PubMed ID: 17090521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery and development of DNA methylation-based biomarkers for lung cancer.
    Walter K; Holcomb T; Januario T; Yauch RL; Du P; Bourgon R; Seshagiri S; Amler LC; Hampton GM; S Shames D
    Epigenomics; 2014 Feb; 6(1):59-72. PubMed ID: 24579947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
    Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
    Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer.
    Sharma A; Heuck CJ; Fazzari MJ; Mehta J; Singhal S; Greally JM; Verma A
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(6):654-69. PubMed ID: 20890963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic regulation as a new target for breast cancer therapy.
    Stearns V; Zhou Q; Davidson NE
    Cancer Invest; 2007 Dec; 25(8):659-65. PubMed ID: 18058459
    [No Abstract]   [Full Text] [Related]  

  • 59. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.
    Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Sukocheva O; Siegert G
    BMC Cancer; 2015 Dec; 15():971. PubMed ID: 26672991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.